Multiple myeloma - bortezomib Initial PBS authority application Supporting information form (PB103)

You must lodge this form for a patient starting initial Pharmaceutical Benefits Scheme (PBS) subsidised treatment with bortezomib for multiple myeloma.

 

Page last updated: 5 February 2016

This information was printed Wednesday 28 September 2016 from humanservices.gov.au/health-professionals/forms/pb103 It may not include all of the relevant information on this topic. Please consider any relevant site notices at humanservices.gov.au/siteinformation when using this material.